Dachaigh › Luchd-obrach › SAI-Med Partners LLC
SAI-Med Partners LLC: Tuarastalan H-1B agus taic bhìosa
Chuir SAI-Med Partners LLC 16 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 16. Tuarastal meadhanach a chaidh a thabhann: $110,000.
A bheil SAI-Med Partners LLC a’ toirt taic do bhìosaichean H-1B?
Chuir SAI-Med Partners LLC 16 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 11 Ògmh 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Life Sciences Markets Consultant/Project Manager | 5 | $100,000 |
| Life Sciences Markets Consultant | 3 | $85,000 |
| Assoc Director - Specialty Therapeutics and Related (STAR) | 1 | $110,000 |
| Senior Director, Oncology Practice | 1 | $145,000 |
| Director - Specialty Therapeutics and Related (STAR) | 1 | $130,000 |
| TheraTraQ Pharma/Healthcare Services Division Head | 1 | $200,000 |
| Associate Director, Immunology Practice | 1 | — |
| Vice President, Oncology Practice | 1 | $185,000 |
| Exec Director - Specialty Therapeutics and Related (STAR) | 1 | $145,000 |
| Associate Director - Generics, Biosimilars and Mature Brands | 1 | $120,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 6 | $97,500 |
| FY2024 | 3 | $150,000 |
| FY2025 | 3 | $100,000 |
| FY2026 | 4 | $132,500 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Associate Director - Generics, Biosimilars and Mature Brands | $120,000–$150,000 Ìre IV | Reading, PA | 11 Ògmh 2026 | 22 Ògmh 2026 | Dearbhaichte |
| Life Sciences Markets Consultant | $85,000–$115,000 Ìre II | Reading, PA | 1 Ògmh 2026 | 8 Ògmh 2026 | Dearbhaichte |
| Exec Director - Specialty Therapeutics and Related (STAR) | $145,000–$230,000 Ìre II | Reading, PA | 9 Gibl 2026 | 15 Cèit 2026 | Dearbhaichte |
| Vice President, Oncology Practice | $185,000–$260,000 Ìre III | Reading, PA | 7 Gibl 2026 | 4 Cèit 2026 | Dearbhaichte |
| Life Sciences Markets Consultant/Project Manager | $88,000–$138,000 Ìre III | Reading, PA | 17 Ògmh 2025 | 24 Ògmh 2025 | Dearbhaichte |
| Life Sciences Markets Consultant/Project Manager | $115,000–$150,000 Ìre III | Reading, PA | 25 Màrt 2025 | 7 Gibl 2025 | Dearbhaichte |
| Life Sciences Markets Consultant/Project Manager | $100,000–$140,000 Ìre III | Reading, PA | 19 Dùbh 2024 | 1 Cèit 2025 | Dearbhaichte |
| Associate Director, Immunology Practice | $135,200–$156,000 pàirt-àm · Ìre II | Reading, PA | 18 Ògmh 2024 | 1 Iuch 2024 | Dearbhaichte |
| Life Sciences Markets Consultant/Project Manager | $100,000–$135,000 Ìre III | Reading, PA | 12 Màrt 2024 | 1 Gibl 2024 | Dearbhaichte |
| TheraTraQ Pharma/Healthcare Services Division Head | $200,000–$400,000 Ìre IV | Reading, PA | 4 Màrt 2024 | 1 Cèit 2024 | Dearbhaichte |
| Life Sciences Markets Consultant/Project Manager | $80,000–$120,000 Ìre III | Reading, PA | 13 Sult 2023 | 3 Dàmh 2023 | Dearbhaichte |
| Senior Director, Oncology Practice | $145,000–$215,000 Ìre III | Reading, PA | 8 Lùna 2023 | 18 Lùna 2023 | Dearbhaichte |
| Director - Specialty Therapeutics and Related (STAR) | $130,000–$170,000 Ìre I | Reading, PA | 17 Iuch 2023 | 1 Lùna 2023 | Dearbhaichte |
| Assoc Director - Specialty Therapeutics and Related (STAR) | $110,000–$160,000 Ìre IV | Reading, PA | 12 Ògmh 2023 | 1 Iuch 2023 | Dearbhaichte |
| Life Sciences Markets Consultant | $85,000–$110,000 Ìre II | Los Angeles, CA | 12 Ògmh 2023 | 24 Ògmh 2023 | Dearbhaichte |
| Life Sciences Markets Consultant | $85,000–$110,000 Ìre II | Reading, PA | 11 Gibl 2023 | 24 Gibl 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).